XML 54 R40.htm IDEA: XBRL DOCUMENT v3.25.1
Segments (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of Financial Data for the Company’s Reportable Segment

The following table presents certain financial data for the Company’s reportable segment (in thousands):

 

Schedule of Financial Data for the Company’s Reportable Segment 

       
   December 31, 
   2024   2023 
Research & development expense – new licenses  $3,114   $ 
Research & development expense – clinical asset development   264    90 
General and administrative expenses – legal & professional fees   2,258    314 
General and administrative expenses – accounting & audit fees   1,625    3,064 
General and administrative expenses – salaries, payroll and stock-based compensation   4,098    721 
General and administrative expenses – other   4,060    1,073 
Loss from segment operations  $15,419   $5,262